Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
March 10, 2021 02:30 ET
|
Ellume Health; Cambridge Consultants
Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test CAMBRIDGE, United Kingdom and BRISBANE, Australia, March 10, 2021 (GLOBE...
Ellume Announces $231.8 Million Agreement with the U.S. Government to Scale Up Production of COVID-19 Home Tests
February 01, 2021 14:17 ET
|
Ellume Health
The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S....
Outlook on the Direct to Consumer Testing Global Industry to 2025
January 22, 2021 04:43 ET
|
Research and Markets
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Direct to Consumer Testing Industry: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides a...
FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test
December 15, 2020 11:29 ET
|
Ellume Health
FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals The test demonstrated 96% accuracy in a multi-site US...
Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study
December 09, 2020 09:00 ET
|
Ellume Health
Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home testClinical study demonstrated overall sensitivity of 95% and specificity of...
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
November 28, 2018 03:00 ET
|
bioLytical Laboratories Inc.
VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in rapid infectious disease tests, is pleased to announce that its INSTI® HIV Self Test has...